Feb06 ASCPT Adviser: February 2025 Highlights and News for February 2025. Read More.. Feb01 I am ASCPT: Chazmyn Riley Chazmyn Riley, PharmD, Fellow, Thomas Jefferson University, Philadelphia, PA Read More.. Feb01 I am ASCPT: Mohamed Elmeliegy Mohamed Elmeliegy, MBA, PhD, Director-Clinical Pharmacology, Pfizer, Trabuco Canyon, CA Read More.. Feb01 I am ASCPT: Sihem Bihorel Sihem Bihorel, PharmD, PhD, Senior Director, Merck & Co, Inc, Chalfont, PA Read More.. Feb01 I am ASCPT: Mathangi Gopalakrishnan Mathangi Gopalakrishnan, PhD, Assistant Professor, University of Maryland, Baltimore, MD Read More.. Jan16 CTS Call for Papers: Biomarkers CTS invites submissions for a special collection dedicated to identifying, assessing, validating,... Read More.. Jan10 FDA News: Issue 1-2, January 2025 FDA Announces the Availability of a Draft Guidance - M15 General Principles for Model-Informed D... Read More.. Jan10 FDA News: Issue 1-1, January 2025 FDA Reopening Comment Period on Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant... Read More.. Jan09 ASCPT Adviser: January 2025 Monthly Highlights You Won’t Want to Miss Read More.. Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74
Feb01 I am ASCPT: Chazmyn Riley Chazmyn Riley, PharmD, Fellow, Thomas Jefferson University, Philadelphia, PA Read More.. Feb01 I am ASCPT: Mohamed Elmeliegy Mohamed Elmeliegy, MBA, PhD, Director-Clinical Pharmacology, Pfizer, Trabuco Canyon, CA Read More.. Feb01 I am ASCPT: Sihem Bihorel Sihem Bihorel, PharmD, PhD, Senior Director, Merck & Co, Inc, Chalfont, PA Read More.. Feb01 I am ASCPT: Mathangi Gopalakrishnan Mathangi Gopalakrishnan, PhD, Assistant Professor, University of Maryland, Baltimore, MD Read More.. Jan16 CTS Call for Papers: Biomarkers CTS invites submissions for a special collection dedicated to identifying, assessing, validating,... Read More.. Jan10 FDA News: Issue 1-2, January 2025 FDA Announces the Availability of a Draft Guidance - M15 General Principles for Model-Informed D... Read More.. Jan10 FDA News: Issue 1-1, January 2025 FDA Reopening Comment Period on Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant... Read More.. Jan09 ASCPT Adviser: January 2025 Monthly Highlights You Won’t Want to Miss Read More.. Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74
Feb01 I am ASCPT: Mohamed Elmeliegy Mohamed Elmeliegy, MBA, PhD, Director-Clinical Pharmacology, Pfizer, Trabuco Canyon, CA Read More.. Feb01 I am ASCPT: Sihem Bihorel Sihem Bihorel, PharmD, PhD, Senior Director, Merck & Co, Inc, Chalfont, PA Read More.. Feb01 I am ASCPT: Mathangi Gopalakrishnan Mathangi Gopalakrishnan, PhD, Assistant Professor, University of Maryland, Baltimore, MD Read More.. Jan16 CTS Call for Papers: Biomarkers CTS invites submissions for a special collection dedicated to identifying, assessing, validating,... Read More.. Jan10 FDA News: Issue 1-2, January 2025 FDA Announces the Availability of a Draft Guidance - M15 General Principles for Model-Informed D... Read More.. Jan10 FDA News: Issue 1-1, January 2025 FDA Reopening Comment Period on Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant... Read More.. Jan09 ASCPT Adviser: January 2025 Monthly Highlights You Won’t Want to Miss Read More.. Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74
Feb01 I am ASCPT: Sihem Bihorel Sihem Bihorel, PharmD, PhD, Senior Director, Merck & Co, Inc, Chalfont, PA Read More.. Feb01 I am ASCPT: Mathangi Gopalakrishnan Mathangi Gopalakrishnan, PhD, Assistant Professor, University of Maryland, Baltimore, MD Read More.. Jan16 CTS Call for Papers: Biomarkers CTS invites submissions for a special collection dedicated to identifying, assessing, validating,... Read More.. Jan10 FDA News: Issue 1-2, January 2025 FDA Announces the Availability of a Draft Guidance - M15 General Principles for Model-Informed D... Read More.. Jan10 FDA News: Issue 1-1, January 2025 FDA Reopening Comment Period on Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant... Read More.. Jan09 ASCPT Adviser: January 2025 Monthly Highlights You Won’t Want to Miss Read More.. Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74
Feb01 I am ASCPT: Mathangi Gopalakrishnan Mathangi Gopalakrishnan, PhD, Assistant Professor, University of Maryland, Baltimore, MD Read More.. Jan16 CTS Call for Papers: Biomarkers CTS invites submissions for a special collection dedicated to identifying, assessing, validating,... Read More.. Jan10 FDA News: Issue 1-2, January 2025 FDA Announces the Availability of a Draft Guidance - M15 General Principles for Model-Informed D... Read More.. Jan10 FDA News: Issue 1-1, January 2025 FDA Reopening Comment Period on Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant... Read More.. Jan09 ASCPT Adviser: January 2025 Monthly Highlights You Won’t Want to Miss Read More.. Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74
Jan16 CTS Call for Papers: Biomarkers CTS invites submissions for a special collection dedicated to identifying, assessing, validating,... Read More.. Jan10 FDA News: Issue 1-2, January 2025 FDA Announces the Availability of a Draft Guidance - M15 General Principles for Model-Informed D... Read More.. Jan10 FDA News: Issue 1-1, January 2025 FDA Reopening Comment Period on Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant... Read More.. Jan09 ASCPT Adviser: January 2025 Monthly Highlights You Won’t Want to Miss Read More.. Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74
Jan10 FDA News: Issue 1-2, January 2025 FDA Announces the Availability of a Draft Guidance - M15 General Principles for Model-Informed D... Read More.. Jan10 FDA News: Issue 1-1, January 2025 FDA Reopening Comment Period on Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant... Read More.. Jan09 ASCPT Adviser: January 2025 Monthly Highlights You Won’t Want to Miss Read More.. Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74
Jan10 FDA News: Issue 1-1, January 2025 FDA Reopening Comment Period on Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant... Read More.. Jan09 ASCPT Adviser: January 2025 Monthly Highlights You Won’t Want to Miss Read More.. Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74
Jan09 ASCPT Adviser: January 2025 Monthly Highlights You Won’t Want to Miss Read More.. Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74
Jan01 I am ASCPT: Andrew Riselli Andrew Riselli, PharmD, Clinical Pharmacology & Therapeutics Fellow, University of California San F... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 of 74